Valeo Financial Advisors’s Genomic Health, Inc. GHDX Stock Holding History

Valeo Financial Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8	Closed	-$1K	–	1780
2019 Q3	$1K	Buy	8 +2	+33%	+$137	﹤0.01%	1531
2019 Q2	$0	Hold	6	–	–	﹤0.01%	1708
2019 Q1	$0	Buy	6 +2	+50%	+$148	﹤0.01%	1673
2018 Q4	$0	Sell	4 -51	-93%	-$3.58K	﹤0.01%	1850
2018 Q3	$4K	Buy	55 +51	+1,275%	+$2.98K	﹤0.01%	1310
2018 Q2	$0	Buy	+4	New	+$159	﹤0.01%	1811

Valeo Financial Advisors's GHDX Position: Q4 2019 in Review

Valeo Financial Advisors sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 8 shares — an estimated $1K sold.

Valeo Financial Advisors first reported a position in GHDX in Q2 2018 and held it in 6 quarters. The position peaked at $4K in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Valeo Financial Advisors reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Valeo Financial Advisors sold 8 Genomic Health, Inc. shares in Q4 2019, an estimated $1K.
Valeo Financial Advisors first reported a position in Genomic Health, Inc. in Q2 2018 and held it in 6 quarters.
Valeo Financial Advisors's Genomic Health, Inc. position peaked at $4K in Q3 2018.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Valeo Financial Advisors's 13F filing for Q4 2019, filed 24 Jan 2020.